- Patent Title: Folate receptor 1 antibodies and immunoconjugates and uses thereof
-
Application No.: US14970436Application Date: 2015-12-15
-
Publication No.: US09670280B2Publication Date: 2017-06-06
- Inventor: Olga Ab , Daniel Tavares , Lingyun Rui , Gillian Payne , Viktor S. Goldmakher
- Applicant: ImmunoGen, Inc.
- Applicant Address: US MA Waltham
- Assignee: ImmunoGen, Inc.
- Current Assignee: ImmunoGen, Inc.
- Current Assignee Address: US MA Waltham
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- Main IPC: C07K16/28
- IPC: C07K16/28 ; C07K16/30 ; A61K39/00 ; A61K51/10 ; A61K47/48 ; A61K39/395 ; A61K45/06 ; A61K31/5365 ; C12N15/63 ; C12N5/16 ; C07H21/00 ; C12N15/62 ; C12N15/70 ; C12N15/79
Abstract:
Novel anti-cancer agents, including, but not limited to, antibodies and immunoconjugates, that bind to human folate receptor 1 are provided. Methods of using the agents, antibodies, or immunoconjugates, such as methods of inhibiting tumor growth are further provided.
Public/Granted literature
- US20160096888A1 Folate Receptor 1 Antibodies and Immunoconjugates and Uses Thereof Public/Granted day:2016-04-07
Information query
